Jun 25, 2026 07:40AM
Jun 23, 2026 07:00AM
Jun 23, 2026 07:00AM
Jun 8, 2026 09:00AM
May 15, 2026 12:12PM
May 15, 2026 12:11PM
May 7, 2026 07:00AM Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results
May 5, 2026 07:01AM
May 5, 2026 07:00AM
Mar 25, 2026 06:57AM
Mar 24, 2026 07:00AM
Mar 24, 2026 07:00AM
Mar 3, 2026 07:00AM
Dec 19, 2025 09:06AM TD Cowen on Biotechnology: '10+ Potential "Thome Run" Catalysts To Watch In 2026'
Dec 5, 2025 09:00AM
Dec 5, 2025 09:00AM
Nov 6, 2025 07:00AM
Oct 20, 2025 07:49AM
Oct 8, 2025 08:44AM
Aug 27, 2025 07:05AM
Aug 27, 2025 07:00AM Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)
Aug 7, 2025 07:00AM
Jul 14, 2025 03:41PM
Jul 13, 2025 05:00PM
Jul 8, 2025 07:00AM
Jun 17, 2025 05:17AM
Jun 3, 2025 07:01AM
Jun 3, 2025 07:00AM Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis
May 12, 2025 07:01AM
May 12, 2025 07:00AM
May 8, 2025 07:00AM
Apr 30, 2025 07:03AM
Apr 30, 2025 07:00AM
Mar 4, 2025 06:00AM
Jan 21, 2025 09:00AM Amylyx Pharmaceuticals (AMLX) Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Trial
Jan 21, 2025 09:00AM
Jan 6, 2025 09:00AM
Dec 4, 2024 07:32AM
Dec 4, 2024 07:30AM
Nov 21, 2024 05:09AM
Nov 7, 2024 07:00AM
Oct 18, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Amylyx Pharmaceuticals inc. (AMLX)
Oct 18, 2024 05:46AM
Oct 17, 2024 09:01AM
Oct 17, 2024 09:00AM
Aug 8, 2024 07:00AM
Aug 2, 2024 09:00AM
Jul 11, 2024 10:30AM
Jul 10, 2024 07:00AM Amylyx Pharmaceuticals (AMLX) Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation
Jul 10, 2024 07:00AM

325,450 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All